FEATURED COMPANIES
- Cipla Ltd.
- GlaxoSmithKline Plc
- Imperial Brands Plc
- Japan Tobacco Inc.
- JUUL Labs Inc.
- Pfizer Inc.
- MORE
1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Global Smoking Cessation And Nicotine De-addiction Market 2020-2024.
The publisher has been monitoring the global smoking cessation and nicotine de-addiction market 2020-2024 and it is poised to grow by USD 16.6 bn during 2020-2024, progressing at a CAGR of 13% during the forecast period. The report on the global smoking cessation and nicotine de-addiction market 2020-2024 provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing number of people trying to quit smoking. In addition, product innovations is anticipated to boost the growth of the global smoking cessation and nicotine de-addiction market 2020-2024 as well.
Market Segmentation
The publisher's global smoking cessation and nicotine de-addiction market 2020-2024 is segmented as below:
Product:
This study identifies product innovations as the prime reasons driving the global smoking cessation and nicotine de-addiction market 2020-2024 growth during the next few years.
Prominent vendors in global smoking cessation and nicotine de-addiction Market 2020-2024.
The publisher provides a detailed analysis of around 25 vendors operating in the global smoking cessation and nicotine de-addiction market 2020-2024, including some of the vendors such as British American Tobacco Plc, Cipla Ltd., Dr. Reddy's Laboratories Ltd., GlaxoSmithKline Plc, Imperial Brands Plc, Japan Tobacco Inc., Johnson & Johnson Services Inc., JUUL Labs Inc., Pfizer Inc. and Philip Morris International Inc. .
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher has been monitoring the global smoking cessation and nicotine de-addiction market 2020-2024 and it is poised to grow by USD 16.6 bn during 2020-2024, progressing at a CAGR of 13% during the forecast period. The report on the global smoking cessation and nicotine de-addiction market 2020-2024 provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing number of people trying to quit smoking. In addition, product innovations is anticipated to boost the growth of the global smoking cessation and nicotine de-addiction market 2020-2024 as well.
Market Segmentation
The publisher's global smoking cessation and nicotine de-addiction market 2020-2024 is segmented as below:
Product:
- E-cigarette
- NRT
- Drug Therapy
- APAC
- Europe
- MEA
- North America
- South America
This study identifies product innovations as the prime reasons driving the global smoking cessation and nicotine de-addiction market 2020-2024 growth during the next few years.
Prominent vendors in global smoking cessation and nicotine de-addiction Market 2020-2024.
The publisher provides a detailed analysis of around 25 vendors operating in the global smoking cessation and nicotine de-addiction market 2020-2024, including some of the vendors such as British American Tobacco Plc, Cipla Ltd., Dr. Reddy's Laboratories Ltd., GlaxoSmithKline Plc, Imperial Brands Plc, Japan Tobacco Inc., Johnson & Johnson Services Inc., JUUL Labs Inc., Pfizer Inc. and Philip Morris International Inc. .
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Cipla Ltd.
- GlaxoSmithKline Plc
- Imperial Brands Plc
- Japan Tobacco Inc.
- JUUL Labs Inc.
- Pfizer Inc.
- MORE
Executive Summary
1. Key Finding 1
2. Key Finding 2
3. Key Finding 3
4. Key Finding 4
5. Key Finding 5
6. Key Finding 6
7. Key Finding 7
8. Market in focus
9. Parent market
10. Market characteristics
11. Product / Service portfolio of key vendors included in the market definition
12. Market segments
13. Global - Market size and forecast 2019 - 2024 ($ billion)
14. Global market: Year-over-year growth 2019 - 2024 (%)
15. Five forces analysis 2019 & 2024
16. Bargaining power of buyers
17. Bargaining power of suppliers
18. Threat of new entrants
19. Threat of substitutes
20. Threat of rivalry
21. Market condition - Five forces 2019
22. Product placement - Market share 2019-2024 (%)
23. Comparison by Product placement
24. E-cigarette - Market size and forecast 2019-2024 ($ billion)
25. E-cigarette - Year-over-year growth 2019-2024 (%)
26. NRT - Market size and forecast 2019-2024 ($ billion)
27. NRT - Year-over-year growth 2019-2024 (%)
28. Drug therapy - Market size and forecast 2019-2024 ($ billion)
29. Drug therapy - Year-over-year growth 2019-2024 (%)
30. Market opportunity by Product
31. Customer landscape
32. Market share by geography 2019-2024 (%)
33. Geographic comparison
34. North America - Market size and forecast 2019-2024 ($ billion)
35. North America - Year-over-year growth 2019-2024 (%)
36. Europe - Market size and forecast 2019-2024 ($ billion)
37. Europe - Year-over-year growth 2019-2024 (%)
38. APAC - Market size and forecast 2019-2024 ($ billion)
39. APAC - Year-over-year growth 2019-2024 (%)
40. South America - Market size and forecast 2019-2024 ($ billion)
41. South America - Year-over-year growth 2019-2024 (%)
42. MEA - Market size and forecast 2019-2024 ($ billion)
43. MEA - Year-over-year growth 2019-2024 (%)
44. Key leading countries
45. Market opportunity by geography ($ billion)
46. Impact of drivers
47. Impact of challenges
48. Landscape disruption
49. Industry risks
50. Vendors covered
51. Market positioning of vendors
52. British American Tobacco Plc - Overview (1/3)
53. British American Tobacco Plc - Overview (2/3)
54. British American Tobacco Plc - Overview (3/3)
55. British American Tobacco Plc - Product and service
56. British American Tobacco Plc - Key offerings
57. British American Tobacco Plc - Key customers
58. British American Tobacco Plc - Segment focus
59. Cipla Ltd. - Overview (1/3)
60. Cipla Ltd. - Overview (2/3)
61. Cipla Ltd. - Overview (3/3)
62. Cipla Ltd. - Business segments
63. Cipla Ltd. - Key offerings
64. Cipla Ltd. - Key customers
65. Cipla Ltd. - Segment focus
66. Dr. Reddy's Laboratories Ltd. - Overview (1/3)
67. Dr. Reddy's Laboratories Ltd. - Overview (2/3)
68. Dr. Reddy's Laboratories Ltd. - Overview (3/3)
69. Dr. Reddy's Laboratories Ltd. - Business segments
70. Dr. Reddy's Laboratories Ltd. - Key offerings
71. Dr. Reddy's Laboratories Ltd. - Key customers
72. Dr. Reddy's Laboratories Ltd. - Segment focus
73. GlaxoSmithKline Plc - Overview (1/3)
74. GlaxoSmithKline Plc - Overview (2/3)
75. GlaxoSmithKline Plc - Overview (3/3)
76. GlaxoSmithKline Plc - Business segments
77. GlaxoSmithKline Plc - Key offerings
78. GlaxoSmithKline Plc - Key customers
79. GlaxoSmithKline Plc - Segment focus
80. Imperial Brands Plc - Overview (1/3)
81. Imperial Brands Plc - Overview (2/3)
82. Imperial Brands Plc - Overview (3/3)
83. Imperial Brands Plc - Business segments
84. Imperial Brands Plc - Key offerings
85. Imperial Brands Plc - Key customers
86. Imperial Brands Plc - Segment focus
87. Japan Tobacco Inc. - Overview (1/3)
88. Japan Tobacco Inc. - Overview (2/3)
89. Japan Tobacco Inc. - Overview (3/3)
90. Japan Tobacco Inc. - Business segments
91. Japan Tobacco Inc. - Key offerings
92. Japan Tobacco Inc. - Key customers
93. Japan Tobacco Inc. - Segment focus
94. Johnson & Johnson Services Inc. - Overview (1/3)
95. Johnson & Johnson Services Inc. - Overview (2/3)
96. Johnson & Johnson Services Inc. - Overview (3/3)
97. Johnson & Johnson Services Inc. - Business segments
98. Johnson & Johnson Services Inc. - Key offerings
99. Johnson & Johnson Services Inc. - Key customers
100. Johnson & Johnson Services Inc. - Segment focus
101. JUUL Labs Inc. - Overview (1/3)
102. JUUL Labs Inc. - Overview (2/3)
103. JUUL Labs Inc. - Overview (3/3)
104. JUUL Labs Inc. - Product and service
105. JUUL Labs Inc. - Key offerings
106. JUUL Labs Inc. - Key customers
107. JUUL Labs Inc. - Segment focus
108. Pfizer Inc. - Overview (1/3)
109. Pfizer Inc. - Overview (2/3)
110. Pfizer Inc. - Overview (3/3)
111. Pfizer Inc. - Business segments
112. Pfizer Inc. - Key offerings
113. Pfizer Inc. - Key customers
114. Pfizer Inc. - Segment focus
115. Philip Morris International Inc. - Overview (1/3)
116. Philip Morris International Inc. - Overview (2/3)
117. Philip Morris International Inc. - Overview (3/3)
118. Philip Morris International Inc. - Business segments
119. Philip Morris International Inc. - Key offerings
120. Philip Morris International Inc. - Key customers
121. Philip Morris International Inc. - Segment focus
122. Currency conversion rates for US$
123. Research Methodology
124. Validation techniques employed for market sizing
125. Information sources
126. List of abbreviations
- Market Overview
- Market ecosystem
- Value chain analysis
- Market definition
- Market segment analysis
- Market size 2019
- Market outlook: Forecast for 2019 - 2024
- Five Forces Summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
- Market segments
- Comparison by Product placement
- E-cigarette - Market size and forecast 2019-2024
- NRT - Market size and forecast 2019-2024
- Drug therapy - Market size and forecast 2019-2024
- Market opportunity by Product
- Overview
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2019-2024
- Europe - Market size and forecast 2019-2024
- APAC - Market size and forecast 2019-2024
- South America - Market size and forecast 2019-2024
- MEA - Market size and forecast 2019-2024
- Key leading countries
- Market opportunity by geography
- Market drivers
- Volume driver - Demand led growth
- Volume driver - Supply led growth
- Volume driver - External factors
- Volume driver - Demand shift in adjacent markets
- Price driver - Inflation
- Price driver - Shift from lower to higher-priced units
- Market challenges
- Market trends
- Overview
- Vendor landscape
- Landscape disruption
- Vendors covered
- Market positioning of vendors
- British American Tobacco Plc
- Cipla Ltd.
- Dr. Reddy's Laboratories Ltd.
- GlaxoSmithKline Plc
- Imperial Brands Plc
- Japan Tobacco, Inc.
- Johnson & Johnson Services Inc.
- JUUL Labs, Inc.
- Pfizer Inc.
- Philip Morris International Inc.
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
1. Key Finding 1
2. Key Finding 2
3. Key Finding 3
4. Key Finding 4
5. Key Finding 5
6. Key Finding 6
7. Key Finding 7
8. Market in focus
9. Parent market
10. Market characteristics
11. Product / Service portfolio of key vendors included in the market definition
12. Market segments
13. Global - Market size and forecast 2019 - 2024 ($ billion)
14. Global market: Year-over-year growth 2019 - 2024 (%)
15. Five forces analysis 2019 & 2024
16. Bargaining power of buyers
17. Bargaining power of suppliers
18. Threat of new entrants
19. Threat of substitutes
20. Threat of rivalry
21. Market condition - Five forces 2019
22. Product placement - Market share 2019-2024 (%)
23. Comparison by Product placement
24. E-cigarette - Market size and forecast 2019-2024 ($ billion)
25. E-cigarette - Year-over-year growth 2019-2024 (%)
26. NRT - Market size and forecast 2019-2024 ($ billion)
27. NRT - Year-over-year growth 2019-2024 (%)
28. Drug therapy - Market size and forecast 2019-2024 ($ billion)
29. Drug therapy - Year-over-year growth 2019-2024 (%)
30. Market opportunity by Product
31. Customer landscape
32. Market share by geography 2019-2024 (%)
33. Geographic comparison
34. North America - Market size and forecast 2019-2024 ($ billion)
35. North America - Year-over-year growth 2019-2024 (%)
36. Europe - Market size and forecast 2019-2024 ($ billion)
37. Europe - Year-over-year growth 2019-2024 (%)
38. APAC - Market size and forecast 2019-2024 ($ billion)
39. APAC - Year-over-year growth 2019-2024 (%)
40. South America - Market size and forecast 2019-2024 ($ billion)
41. South America - Year-over-year growth 2019-2024 (%)
42. MEA - Market size and forecast 2019-2024 ($ billion)
43. MEA - Year-over-year growth 2019-2024 (%)
44. Key leading countries
45. Market opportunity by geography ($ billion)
46. Impact of drivers
47. Impact of challenges
48. Landscape disruption
49. Industry risks
50. Vendors covered
51. Market positioning of vendors
52. British American Tobacco Plc - Overview (1/3)
53. British American Tobacco Plc - Overview (2/3)
54. British American Tobacco Plc - Overview (3/3)
55. British American Tobacco Plc - Product and service
56. British American Tobacco Plc - Key offerings
57. British American Tobacco Plc - Key customers
58. British American Tobacco Plc - Segment focus
59. Cipla Ltd. - Overview (1/3)
60. Cipla Ltd. - Overview (2/3)
61. Cipla Ltd. - Overview (3/3)
62. Cipla Ltd. - Business segments
63. Cipla Ltd. - Key offerings
64. Cipla Ltd. - Key customers
65. Cipla Ltd. - Segment focus
66. Dr. Reddy's Laboratories Ltd. - Overview (1/3)
67. Dr. Reddy's Laboratories Ltd. - Overview (2/3)
68. Dr. Reddy's Laboratories Ltd. - Overview (3/3)
69. Dr. Reddy's Laboratories Ltd. - Business segments
70. Dr. Reddy's Laboratories Ltd. - Key offerings
71. Dr. Reddy's Laboratories Ltd. - Key customers
72. Dr. Reddy's Laboratories Ltd. - Segment focus
73. GlaxoSmithKline Plc - Overview (1/3)
74. GlaxoSmithKline Plc - Overview (2/3)
75. GlaxoSmithKline Plc - Overview (3/3)
76. GlaxoSmithKline Plc - Business segments
77. GlaxoSmithKline Plc - Key offerings
78. GlaxoSmithKline Plc - Key customers
79. GlaxoSmithKline Plc - Segment focus
80. Imperial Brands Plc - Overview (1/3)
81. Imperial Brands Plc - Overview (2/3)
82. Imperial Brands Plc - Overview (3/3)
83. Imperial Brands Plc - Business segments
84. Imperial Brands Plc - Key offerings
85. Imperial Brands Plc - Key customers
86. Imperial Brands Plc - Segment focus
87. Japan Tobacco Inc. - Overview (1/3)
88. Japan Tobacco Inc. - Overview (2/3)
89. Japan Tobacco Inc. - Overview (3/3)
90. Japan Tobacco Inc. - Business segments
91. Japan Tobacco Inc. - Key offerings
92. Japan Tobacco Inc. - Key customers
93. Japan Tobacco Inc. - Segment focus
94. Johnson & Johnson Services Inc. - Overview (1/3)
95. Johnson & Johnson Services Inc. - Overview (2/3)
96. Johnson & Johnson Services Inc. - Overview (3/3)
97. Johnson & Johnson Services Inc. - Business segments
98. Johnson & Johnson Services Inc. - Key offerings
99. Johnson & Johnson Services Inc. - Key customers
100. Johnson & Johnson Services Inc. - Segment focus
101. JUUL Labs Inc. - Overview (1/3)
102. JUUL Labs Inc. - Overview (2/3)
103. JUUL Labs Inc. - Overview (3/3)
104. JUUL Labs Inc. - Product and service
105. JUUL Labs Inc. - Key offerings
106. JUUL Labs Inc. - Key customers
107. JUUL Labs Inc. - Segment focus
108. Pfizer Inc. - Overview (1/3)
109. Pfizer Inc. - Overview (2/3)
110. Pfizer Inc. - Overview (3/3)
111. Pfizer Inc. - Business segments
112. Pfizer Inc. - Key offerings
113. Pfizer Inc. - Key customers
114. Pfizer Inc. - Segment focus
115. Philip Morris International Inc. - Overview (1/3)
116. Philip Morris International Inc. - Overview (2/3)
117. Philip Morris International Inc. - Overview (3/3)
118. Philip Morris International Inc. - Business segments
119. Philip Morris International Inc. - Key offerings
120. Philip Morris International Inc. - Key customers
121. Philip Morris International Inc. - Segment focus
122. Currency conversion rates for US$
123. Research Methodology
124. Validation techniques employed for market sizing
125. Information sources
126. List of abbreviations
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Cipla Ltd.
- GlaxoSmithKline Plc
- Imperial Brands Plc
- Japan Tobacco Inc.
- JUUL Labs Inc.
- Pfizer Inc.
- MORE
The publisher Announces the Publication of its Research Report-Global Smoking Cessation And Nicotine De-addiction Market 2020-2024.
The publisher recognizes the following companies as the key players in the global smoking cessation and nicotine de-addiction market: British American Tobacco Plc, Cipla Ltd., Dr. Reddy's Laboratories Ltd., GlaxoSmithKline Plc, Imperial Brands Plc, Japan Tobacco Inc., Johnson & Johnson Services Inc., JUUL Labs Inc., Pfizer Inc. and Philip Morris International Inc..
Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is the product innovations."
According to the report, one of the major drivers for this market is the increasing number of people trying to quit smoking.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
The publisher recognizes the following companies as the key players in the global smoking cessation and nicotine de-addiction market: British American Tobacco Plc, Cipla Ltd., Dr. Reddy's Laboratories Ltd., GlaxoSmithKline Plc, Imperial Brands Plc, Japan Tobacco Inc., Johnson & Johnson Services Inc., JUUL Labs Inc., Pfizer Inc. and Philip Morris International Inc..
Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is the product innovations."
According to the report, one of the major drivers for this market is the increasing number of people trying to quit smoking.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
- British American Tobacco Plc
- Cipla Ltd.
- Dr. Reddy's Laboratories Ltd.
- GlaxoSmithKline Plc
- Imperial Brands Plc
- Japan Tobacco Inc.
- Johnson & Johnson Services Inc.
- JUUL Labs Inc.
- Pfizer Inc.
- Philip Morris International Inc.
Note: Product cover images may vary from those shown
LOADING...
